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Introduction
Plasmacytoma is malignant proliferation of a
monoclonal population of plasma cells all produc-
ing the same immunoglobulin. This plasma cell
malignancy accounts for <1% of all cancers and
for 10% of the hematological malignancies(1).
Usually this tumor is located in bone marrow as
solitary bone plasmacytoma (SBP), although some-
times it can be found in soft tissue as
extramedullary plasmacytoma (EMP) or be a part
of the multifocal disseminated disease multiple
myeloma (MM)(2). Particularly EMP accounts for
less than 3-4% of all plasma cell neoplasms and for
4% of all non-epithelial tumors of the upper air-
ways(3).
The median age of EMP onset is 55 years and
75% of affected patients are men. In the 80% of
cases it is localized submucosally, mainly in the
head and neck region, particularly in the nasal cav-
ity and/or paranasal sinuses (43%), nasopharynx
(18.3%), oropharynx (17.8%) and tonsils (<10%).
There are no identifiable risk factors(4,5,6,7,8,9,10).
Symptoms and signs depend on the EMP’s
location, but the most frequent are pain, swelling
and obstruction of the respiratory tract or oral cavity. 
The authors describe the 5th case of EMP of
the tonsil reported by literature making a review
with respect to evaluation and management of this
tumor.
Case presentation
A 57-year-old Caucasian male worker was
admitted to our section on May 2009. He was life-
long nonsmoker and denied alcohol consumption.
He complained a painless right-upper neck mass
rapidly increased in size during the last month. The
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ABSTRACT
Introduction: Extramedullary plasmacytoma (EMP) is a rare tumor of all plasma cell neoplasms. The tumor is mainly locali-
zed in the head and neck region, but rarely involving the tonsil. 
Case presentation: The authors report the 5th case of EMP of the tonsil in the literature occurred in a 57-year-old Caucasian
male.
Conclusions: Through a review of the relevant literature, we consider adjuvant radiotherapy not necessary for EMP of tonsil
because of an adequate resection achieved by surgery.
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patient did not report other disorders; in particular
his family and medical history was unremarkable,
he denied loss of weight, other masses, swallowing
or breathing difficulties. Physical examination
revealed only a palpable, freely mobile and non-
tender right level II lymph node comprise between 2
and 4 cm. Oropharyngeal examination showed a
moderately enlarged right tonsil with mucosal
telangiectasias and elevation of the lateral floor. No
pulsations were detectable; flexible fiberoptic
nasopharyngoscopy was normal.
CT (computerized tomography) of the neck
evidenced ovoid nonspecific soft tissue masses, like-
ly a lymph nodes (Figure 1a), and a mass in the right
tonsillar fossa suspicious for a primary tumor
(Figure 1b).
So CT imaging supported the clinical diagnosis
of a tonsillar primary lesion with a regional lymph
nodal involvement. Suspecting a malign lesion an
excision biopsy (tonsillectomy) of right tonsil was
performed (Figure 2a) and, after extemporaneous
examination predicting for plasmacytoma, a neck
dissection was carried out (Figure 2b).
Histological examination of the tonsillar mass
showed dense plasmacells with a monotone aspect.
They possessed a round to oval nucleus with a
vesicular nuclear chromatin pattern. The nucleus is
often located eccentrically in the cytoplasm (perinu-
clear halo). The tonsillar lesion was fairly circum-
scribed and the epithelium was not infiltrated.
The lymph nodes showed alteration of normal
architecture and extensive infiltration of neoplastic
cells possessing plasmacytoid morphology.
Further immunocytochemistric analysis on the
specimens showed CD138 plasma cell marker posi-
tivity with concomitant cytoplasmic expression of
kappa light chains, while CD20 and CD3 were neg-
ative. This profile confirmed the diagnosis of plas-
macytoma (Figure 3 a and b). Serum protein elec-
trophoresis showed the presence of monoclonal IgG
with kappa light chain with normal levels of residual
immunoglobulins. Lumbar puncture, skeletal survey
and Bence-Jones protein in urine were performed
with anything relevant. After surgery, at 3 monthly
intervals for the first year, the patient was con-
trolled. Monoclonal IgG and kappa light chains
plasma levels were normalized. Bone marrow biop-
sy resulted negative for multiple myeloma and
skeletal survey was negative for coexisting lesions.
The patient underwent new examination at 6 month-
ly intervals for the second year, and then annually;
to date he remains free of disease.
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Figure 1. a) Axial Computerized Tomography, with con-
trast media, showing enlarged right level II lymph node
that push the submandibular gland; b) Axial
Computerized Tomography, with contrast media,
showing a mass in the right tonsillar fossa suspicious for
a primary tumor.
Figure 2. a) Axial Computerized Tomography, with con-
trast media, showing right tonsillar fossa free from pri-
mary tumor three years after tonsillectomy; b) Axial
Computerized Tomography, with contrast media,
showing the absence of lymph nodes three years after
neck dissection.
Figure 3. Tissue sampling of Extramedullary plasmacy-
toma (EMP) and immunohistochemical staining. a)
Positive staining of CD138; b) positive staining for
kappa light chains.
Discussion 
The exact incidence of extramedullary plasma-
cytomas (EMP) is unknown, but it represents only
3-4% of all plasma cell malignancies(8). In the 80%
of patients, EMP occurs in the upperairways, with
an involvement of the tonsil in 10.5% of cases(8).
So far, only 5 cases of tonsillar EMP have been
described in the literature (Table I).
Kalan et al reported a EMP of tonsil treated
with radiotherapy alone (4500 cGY in 20 frac-
tions)(11).
Bazaadut et al reported EMP arose from the
right tonsil with involved ipsilateral lymph node as
in our case. The lesion was removed by tonsillecto-
my but neck dissection was not performed because
these authors make it when extemporaneous exami-
nation shows a squamous cell carcinoma(12).
The other authors reported cases of the same
tumor, treated by tonsillectomy and/or neck dissec-
tion when lymph nodes were involved, without per-
forming the examination extemporaneous(13,14).
As suggested by “guidelines on the diagnosis
and management of solitary bone plasmacytoma and
extramedullary plasmacytoma” (2004) the manage-
ment of our case included full history of patient,
clinical examination of nose, throat, neck region and
nasopharyngoscopy(15). Fine-needle aspiration biopsy
(FNA) of the neck mass was not performed because
it doesn’t provide conclusive results because it does-
n’t distinguish with absolute certainty between
inflammatory condition and malignant lesion(16). In
fact it is universally accepted that only pathology
exam of primary lesion and/or lymph nodes associ-
ated, especially if accompanied by immunocyto-
chemistric analysis(16), is able to confirm the diagno-
sis especially through positive plasma cells that
express CD138 with concomitant cytoplasmic
expression of kappa or lambda light chains(16). 
Imaging studies such as CT, Magnetic reso-
nance imaging (MRI) and Positron Emission
Tomography (PET) can help evaluating the local
extension of disease, involvement of lymph nodes
and bone structures and the choose of adjuvant
radiotherapy(4).
Baseline full blood examination, serum calci-
um, urea, and electrolytes should be performed in
addition to serum protein electrophoresis and
immunofixation, urine Bence-Jones proteins,
skeletal survey, and bone marrow examination.
In particular serum protein electrophoresis can
show the presence of monoclonal IgG with
kappa or lambda light chain with normal levels
of residual immunoglobulins. As in this subject
the commonest immunoglobulin evidenced is
IgG with kappa light chain restriction. This
serological profile is associated with the lowest
rate of progression to MM, while cases with
prevalence of lambda light chain are more like-
ly to progress to MM. Solitary EMP manage-
ment includes radiotherapy, surgery, or both
techniques. Literature reveal no advantages of
chemotherapy administration. EMP respond well to
radiation therapy and some advocate use of radia-
tion as primary treatment(2,11). In contrast to Kalan et
al, the authors suggest that if disease is localized in
the head and neck and amenable to complete resec-
tion, surgery is advocated also because radiation
therapy may involve major organs such as the thy-
roid and salivary glands with sequelae. In contrast to
Bazaadut and to other authors, if extemporaneous
examination predict for plasmacytoma and lymph
nodal involvement is localized, the authors prefer to
perform neck dissection because this tumor can
metastasize; therefore complete surgical resection
must be preferred to radiotherapy(15) even if some
authors affirm that approximately 10-30% of treated
patients distant failure seem to occur(15). This fact
usually occurs within 2 years after diagnosis(4). For
this reason, we recommend a complete reassessment
every three months in the first year, every six month
in the second year, and annually thereafter for life.
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